The immunogenicity of autologous tumor-associated antigens (TAAs) is markedly increased upon the intratumoral injection of -gal glycolipids, which insert into tumor cell membranes. from the disease fighting capability against the main one or many autologous tumor-associated antigens (TAAs). The disease fighting capability is with the capacity of avoiding tumor cells delivering TAAs, as possible inferred… Continue reading The immunogenicity of autologous tumor-associated antigens (TAAs) is markedly increased upon